Rat PD1 / PDCD1 / CD279 Protein (His Tag, ECD) 80448-R08H from Sino Biological, Inc. | Biocompare.com

Supplier Images

Rat PD1 / PDCD1 / CD279 Protein (His Tag, ECD)

Rat PD1 / PDCD1 / CD279 Protein (His Tag, ECD)

Be the first to write a review!

Citations:

Supplier Page from
Sino Biological, Inc. for
Rat PD1 / PDCD1 / CD279 Protein (His Tag, ECD)

Description

A DNA sequence encoding the rat PDCD1 (NP_001100397.1) (Met1-Gln167) was expressed with a polyhistidine tag at the C-terminus

Product Specs
ItemRat PD1 / PDCD1 / CD279 Protein (His Tag, ECD)
CompanySino Biological, Inc.
Price $298.00Supplier Page View Company Product Page
Catalog Number80448-R08H
Size100 µg
Conjugate/TagC-His
Purity≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC
Activity1. Measured by its ability to bind PD-L1 Protein, Human, Recombinant (ECD, His Tag), Biotinylated(Cat:10084-H08H-B) in a functional ELISA. 2. Immobilized PD-1 Protein, Rat, Recombinant (ECD, His Tag)(Cat:80448-R08H) at 2 µg/ml (100 µl/well) can bind PD-L1 Protein, Mouse, Recombinant (ECD, hFc Tag)(Cat:50010-M02H), the EC50 of human B7-H1 is 30-200 ng/mL
FormatLyophilized from sterile PBS, pH 7.4
TypeRecombinant protein
Molecular WeightThe recombinant rat PDCD1 consists of 154 amino acids and predicts a molecular mass of 17.7 kDa. It migrates as an approximately 34.8 kDa band in SDS-PAGE under reducing conditions
SpeciesRat
Molecule NamePDCD1
Source/Expression SystemHEK293 Cells
NCBI Full Gene Nameprogrammed cell death 1

Add to Compare List

Sino Biological, Inc.

Sino Biological, Inc.

37 Industrial Blvd

Suite B

Paoli, PA 19301

United States

Phone: 215-583-7898
Fax: 267-657-0217

Email: marketing@sinobiological.com

Company Profile

Website: sinobiological.com

(1) Discovery and pharmacological characterization of cetrelimab (JNJ-63723283), an anti-programmed cell death protein-1 (PD-1) antibody, in human cancer modelsCancer chemotherapy and pharmacologyApril 1, 2022DeAngelis N, Ferrante C, Powers G, Sendecki J, Mattson B, Pizutti D, Packman K, Wang W, Trouba K, Nanjunda R, et al.

(2) RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaEMBO molecular medicineJune 8, 2020Smith HG, Jamal K, Dayal JH, Tenev T, Kyula-Currie J, Guppy N, Gazinska P, Roulstone V, Liccardi G, Davies E, et al.

Be the First to Write a Review!